Testing a blood-filter treatment in critically ill ICU patients
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to the ICU (intensive care unit).
- You are already planned to receive a blood-cleaning treatment through a machine, such as CRRT, intermittent hemodialysis, or a similar hybrid method.
- Your care team plans an immune/inflammation-focused filtering approach using specific filters or cartridges (or a method aimed at removing inflammatory signals or toxins).
- A study-approved blood-filter option is not a medical no-go for you based on the device instructions (contraindications).
- Your treating doctor decides you need this kind of treatment as part of your critical care plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.